Annual ROE:
-32.04%+10.57%(+24.81%)Summary
- As of today, ELVN annual return on equity is -32.04%, with the most recent change of +10.57% (+24.81%) on December 31, 2024.
- During the last 3 years, ELVN annual ROE has fallen by -6.17% (-23.85%).
- ELVN annual ROE is now -166.71% below its all-time high of 48.03%, reached on December 1, 2019.
Performance
ELVN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
-26.26%+3.57%(+11.97%)Summary
- As of today, ELVN quarterly return on equity is -26.26%, with the most recent change of +3.57% (+11.97%) on September 30, 2025.
- Over the past year, ELVN quarterly ROE has increased by +3.77% (+12.55%).
- ELVN quarterly ROE is now -573.15% below its all-time high of 5.55%, reached on December 31, 2022.
Performance
ELVN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ELVN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +24.8% | +12.6% |
| 3Y3 Years | -23.9% | +53.4% |
| 5Y5 Years | -166.7% | +26.5% |
ELVN ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -2221.8% | +24.8% | -573.1% | +53.4% |
| 5Y | 5-Year | -166.7% | +86.2% | -573.1% | +58.0% |
| All-Time | All-Time | -166.7% | +86.2% | -573.1% | +58.0% |
ELVN ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | -26.26%(+12.0%) |
| Jun 2025 | - | -29.83%(+5.1%) |
| Mar 2025 | - | -31.42%(-3.5%) |
| Dec 2024 | -32.04%(+24.8%) | -30.35%(-1.1%) |
| Sep 2024 | - | -30.03%(-2.2%) |
| Jun 2024 | - | -29.39%(-3.1%) |
| Mar 2024 | - | -28.51%(+7.0%) |
| Dec 2023 | -42.61%(-2921.9%) | -30.64%(-199.8%) |
| Sep 2023 | - | -10.22%(-62.2%) |
| Jun 2023 | - | -6.30%(-264.2%) |
| Mar 2023 | - | -1.73%(-131.2%) |
| Dec 2022 | 1.51% | 5.55%(+109.8%) |
| Sep 2022 | - | -56.35%(+4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -59.25%(+5.2%) |
| Mar 2022 | - | -62.50%(+0.2%) |
| Dec 2021 | -25.87%(+88.9%) | - |
| Dec 2021 | - | -62.60%(-8.0%) |
| Sep 2021 | - | -57.97%(-4.3%) |
| Jun 2021 | - | -55.59%(-16.7%) |
| Mar 2021 | - | -47.62%(-12.4%) |
| Dec 2020 | -232.44%(-583.9%) | -42.35%(-18.5%) |
| Sep 2020 | - | -35.73%(-57.2%) |
| Jun 2020 | - | -22.73%(-72.9%) |
| Mar 2020 | - | -13.15% |
| Dec 2019 | 48.03%(+11.5%) | - |
| Dec 2018 | 43.08%(+3133.8%) | - |
| Dec 2017 | -1.42% | - |
FAQ
- What is Enliven Therapeutics, Inc. annual return on equity?
- What is the all-time high annual ROE for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual ROE year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly ROE year-on-year change?
What is Enliven Therapeutics, Inc. annual return on equity?
The current annual ROE of ELVN is -32.04%
What is the all-time high annual ROE for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual return on equity is 48.03%
What is Enliven Therapeutics, Inc. annual ROE year-on-year change?
Over the past year, ELVN annual return on equity has changed by +10.57% (+24.81%)
What is Enliven Therapeutics, Inc. quarterly return on equity?
The current quarterly ROE of ELVN is -26.26%
What is the all-time high quarterly ROE for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly return on equity is 5.55%
What is Enliven Therapeutics, Inc. quarterly ROE year-on-year change?
Over the past year, ELVN quarterly return on equity has changed by +3.77% (+12.55%)